Prevention and treatment of skin and nail infections using germicidal light

• US 7,306,620 B2
• Filed: 06/17/2005
• Issued: 12/11/2007
• Est. Priority Date: 02/11/2002
• Status: Expired due to Fees

• Current Assignee: Keraderm Corporation
• Original Assignee: Keraderm Corporation
• Inventors: Cumbie, William E.
• Primary Examiner(s): FARAH, AHMED M
• Application Number:
  US11/154,707
• Publication Number:
  US 20060004425A1
• Time in Patent Office: 907 Days
• Field of Search: 607/88, 607/89, 606/3, 606/9, 128/898
• US Class Current: 607/88
• CPC Class Codes: A61B 2018/00452 Skin
• CPC Class Codes: A61B 2018/1807 using light other than laser radiation
• CPC Class Codes: A61B 2018/2015 Miscellaneous features
• CPC Class Codes: A61L 2/10 Ultraviolet radiation
• CPC Class Codes: A61N 2005/0643 Applicators, probes irradiating specific body areas in close proximity
• CPC Class Codes: A61N 2005/0654 Lamps
• CPC Class Codes: A61N 2005/0661 ultraviolet
• CPC Class Codes: A61N 5/0616 Skin treatment other than tanning
• CPC Class Codes: A61N 5/0624 for eliminating microbes, germs, bacteria on or in the body

Abstract

A method of prevention and treatment of microbial infections that occur on, or just below, the skin and nails of a person consisting of electromagnetic radiation to inactivate the microbes thus rendering them harmless. The treatment consists of irradiating an area of the skin and nails for a period of time long enough to inactivate the organisms. Some additional features which are not integral to the treatment but increase the safety of the treatment include shielding of non-infected areas from irradiation and a cover to prevent damage to sight which may result from viewing the electromagnetic radiation.

Claims

1. A method of treating a microbial infection in a patient, comprising:

evaluating the infection;

calculating an amount of energy required to inactivate microbes in the infection;

calculating an amount of the light of about 100 nm to 400 nm that is required to achieve the amount of energy, wherein calculating includes taking into account at least depth of area with the infection through which the light must be transmitted; and

administering the amount of light to the infection, wherein the intensity of the light at least substantially inactivates microbes in the infection and wherein no light absorbing substance is added to the microbes.

2. The method of claim 1, wherein the light is absorbed directly by genetic material of the microbes, the genetic material being at least one of RNA and DNA.

3. The method of claim 2, wherein the light absorption causes dimerization of at least some pyrimidine molecules of the at least one of the RNA and DNA.

4. The method of claim 1, wherein administering light to the infection does not cause severe erythema of area surrounding the infection.

5. The method of claim 1, wherein administering light to the infection does not substantially raise the temperature of area surrounding the infection.

6. The method of claim 1, where administering light to the infection includes administering light to multiple locations in a single application.

7. The method of claim 1, wherein administering light to the infection includes administering light in multiple discrete applications.

8. The method of claim 7, wherein administering light in multiple discrete applications includes administering an amount of radiation of about 5 to 10,000 mj/cm² during each of the discrete applications.

9. The method of claim 7, wherein administering light in multiple discrete applications includes administering an amount of radiation of about 5 mj/cm² to 100 j/cm² during each of the discrete applications.

10. The method of claim 1, wherein administering light to the infection includes administering light with a xenon light source.

11. The method of claim 1, wherein administering light to the infection includes administering a multispectrum light having a substantial portion of the administered light of about 100 nm to 400 nm.

12. The method of claim 1, wherein administering light to the infection includes administering a multispectrum light having a substantial portion of administered light of about 170 nm to 2600 nm.

13. The method of claim 1, wherein administering light to the infection includes administering a pulsed polychromatic light having a substantial portion of the administered light of about 100 nm to 400 nm.

14. The method of claim 1, wherein administering light to the infection includes administering a broad spectrum pulse light source and administering at least 1.25 J/cm² of energy to the infection.

15. The method of claim 1, wherein administering light to the infection includes administering light of about 240 nm to 280 nm.

16. The method of claim 1, wherein administering light to the infection includes administering light of about 240 nm to 315 nm.

17. The method of claim 1, wherein administering light to the infection consists of administering light at a range and amount that is insufficient to kill all of the microbes.

18. The method of claim 1, wherein administering light to the infection includes administering light outside of the ultraviolet range to enhance treatment of the infection.

19. The method of claim 1, wherein the infection is in a nail of the patient.

20. The method of claim 1, wherein the patient is an animal.

21. The method of claim 1, further comprising, administering light to area with the infection prior to detecting visible signs of the infection.

22. A method of treating a microbial infection in a patient, comprising:

evaluating the infection;

calculating an amount of the light of about 100 nm to 400 nm that is required to achieve at least 1.25 J/cm2 amount of energy, wherein calculating includes taking into account at least depth of area with the infection through which the light must be transmitted; and

administering the amount of light to the infection, wherein the intensity of the light at least substantially inactivates microbes in the infection and wherein no light absorbing substance is added to the microbes.

23. The method of claim 22, where administering light to the infection includes administering light to multiple locations in a single application.

24. The method of claim 22, wherein administering light to the infection includes administering light in multiple discrete applications.

25. The method of claim 24, wherein administering light in multiple discrete applications includes administering an amount of radiation of about 5 to 10,000 mj/cm² during each of the discrete applications.

26. The method of claim 24, wherein administering light in multiple discrete applications includes administering an amount of radiation of about 5 mj/cm² to 100 j/cm² during each of the discrete applications.

27. The method of claim 22, wherein administering light to the infection includes administering light with a xenon light source.

28. The method of claim 22, wherein administering light to the infection includes administering a multispectrum light having a substantial portion of the administered light of about 100 nm to 400 nm.

29. The method of claim 22, wherein administering light to the infection includes administering a multispectrum light having a substantial portion of administered light of about 170 nm to 2600 nm.

30. The method of claim 22, wherein administering light to the infection includes administering a pulsed polychromatic light having a substantial portion of the administered light of about 100 nm to 400 nm.

31. The method of claim 22, wherein administering light to the infection includes administering a broad spectrum pulse light source.

32. The method of claim 22, wherein administering light to the infection includes administering light of about 240 nm to 280 nm.

33. The method of claim 22, wherein administering light to the infection includes administering light of about 240 nm to 315 nm.

34. The method of claim 22, wherein administering light to the infection includes administering light outside of the ultraviolet range to enhance treatment of the infection.

35. The method of claim 22, wherein the infection is in a nail of the patient.

36. The method of claim 22, wherein the patient is an animal.

37. The method of claim 22, further comprising, administering light to area with the infection prior to detecting visible signs of the infection.

38. A method of treating a microbial infection in a nail of a patient comprising:

administering electromagnetic radiation of about 100 to 280 nm to an infected nail of the patient for a time and at a proximity and intensity sufficient to render microbes in the infection substantially incapable of reproducing by disruption of cellular processes of the microbes while insufficient to kill all of the microbes.

39. The method of claim 38, wherein administering electromagnetic radiation causes dimerization of at least some pyrimidine molecules of at least one of the RNA or DNA of the microbes.

40. The method of claim 38, wherein administering electromagnetic radiation to the infection does not cause severe erythema of area surrounding the infection.

41. The method of claim 38, wherein administering electromagnetic radiation to the infection does not excessively heat area with the infection or area surrounding the infection.

42. The method of claim 38, where administering electromagnetic radiation to the infection includes administering electromagnetic radiation to multiple locations in a single application.

43. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering electromagnetic radiation in multiple discrete applications.

44. The method of claim 43, wherein administering electromagnetic radiation in discrete applications includes administering an amount of radiation of about 5 to 10,000 mj/cm² to the infection during each of the discrete applications.

45. The method of claim 43, wherein administering light in multiple discrete applications includes administering an amount of radiation of about 5 mj/cm² to 100 j/cm² during each of the discrete applications.

46. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering light with a xenon light source.

47. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering a multispectrum light having a substantial portion of the administered light of about 240 nm to 280 nm.

48. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering a multispectrum light having a substantial portion of administered light of about 170 nm to 2600 nm.

49. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering a pulsed polychromatic light having a substantial portion of the administered light of about 240 nm to 280 nm.

50. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering a broad spectrum pulse light source and administering at least 1.25 J/cm² of energy to the infection.

51. The method of claim 38, further comprising:

evaluating the infection;

calculating an amount of energy required to inactivate the microbes in the infection; and

calculating an amount of the light of about 240 nm to 280 nm that is required to be administered to achieve the required amount of energy, wherein calculating includes taking into account at least depth of area with the infection through which the light must be transmitted.

52. The method of claim 38, wherein administering electromagnetic radiation to the infection includes administering light outside of the ultraviolet range to enhance treatment of the infection.

53. The method of claim 38, wherein the patient is an animal.

54. The method of claim 38, further comprising, administering electromagnetic radiation to area with the infection prior to detecting visible signs of the infection.